Onconetix, Inc. (ONCO) Latest News

NASDAQ Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$0.00

$0 (0%)

Last update: 07:00 PM EST

Day's range

$0.44

$0.54

Latest News of ONCO

CG Oncology announces data from Phase 3 BOND-003 trial

CG Oncology announces data from Phase 3 BOND-003 trial

By Yahoo! Finance | 1 year ago

I'm an oncology dietitian -- the best pizza toppings to reduce your...

I'm an oncology dietitian -- the best pizza toppings to reduce your...

By New York Post | 1 year ago

HMC relocates oncology and physiotherapy department to QRI

HMC relocates oncology and physiotherapy department to QRI

By Yahoo! Finance | 1 year ago

Mural Oncology plc (MURA) Stock Price, News, Quote & History

Mural Oncology plc (MURA) Stock Price, News, Quote & History

By Yahoo! Finance | 1 year ago

Ford reassigns hundreds in Michigan as it adjusts Bronco production

Ford reassigns hundreds in Michigan as it adjusts Bronco production

By Yahoo! Finance | 1 year ago

Want a Ford Bronco Raptor pickup truck? SoFlo Customs has done the work for you

Want a Ford Bronco Raptor pickup truck? SoFlo Customs has done the work for you

By USA Today | 1 year ago

Ford to Cut Bronco Production

Ford to Cut Bronco Production

By Yahoo! Finance | 1 year ago

Kura Oncology Shares Fall 14% on Plans for Cancer-Drug Collaboration

Kura Oncology Shares Fall 14% on Plans for Cancer-Drug Collaboration

By MarketWatch | 1 year ago

BioNTech SE's Strategic Growth in Oncology and mRNA

BioNTech SE's Strategic Growth in Oncology and mRNA

By Yahoo! Finance | 1 year ago

The Oncology Institute Inc (TOI) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst ...

The Oncology Institute Inc (TOI) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst ...

By Yahoo! Finance | 1 year ago

CG Oncology Getting Closer To Key Technical Benchmark

CG Oncology Getting Closer To Key Technical Benchmark

By Investor's Business Daily | 1 year ago

Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside

Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside

By Yahoo! Finance | 1 year ago